RECALLS AND SAFETY ALERTS CAUTION ON VIRACEPT IN CHILDREN AND PREGNANT WOMEN
December 5, 2007
Pfizer is advising healthcare professionals to avoid treating certain children and pregnant women with the antiretroviral drug Viracept (nelfinavir mesylate).
The company says that patients taking Viracept have the potential to be exposed to an...
Additional Legal Resources: